A Novel Nomogram Based on ALBI Grade and Dynamic SII for Predicting Prognosis of Unresectable HCC Treated With TACE Plus Toripalimab

Yanjun Pu, Fen He, Xuyin Wang, Tong Lu, Jing Wang

PDF(4401 KB)
For Authors|For Editors|For Reviewers
PDF(4401 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (207) : 1195-1209. DOI: 10.24976/Discov.Med.202638207.95
Article

A Novel Nomogram Based on ALBI Grade and Dynamic SII for Predicting Prognosis of Unresectable HCC Treated With TACE Plus Toripalimab

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(207): 1195-1209 https://doi.org/10.24976/Discov.Med.202638207.95

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(4401 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉